Allogeneic anti-CD7 CAR-T cells (BEAM-201) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BEAM-201

Filter by location:

Philadelphia, Pennsylvania1 trial

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Children's Hospital of Philadelphia

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.